Marlyn Mayo, MD

Marlyn Mayo, MD, is a professor of internal medicine at UT Southwestern Medical Center.

Articles by Marlyn Mayo, MD

Elafibranor Sustains Biochemical Response Across PBC Stages Through 4 Years

Seladelpar Linked to Sustained IL-31 Reduction in PBC in New Study

November 6th 2026

Marlyn Mayo, MD, discusses long-term seladelpar data linking IL-31 reductions to PBC pruritus improvement and why the cytokine is not ready to guide treatment.

Elafibranor Sustains Biochemical Response Across PBC Stages Through 4 Years

ByMarlyn Mayo, MD

November 6th 2026

Marlyn Mayo, MD, discusses 4-year ELATIVE data on elafibranor sustaining biochemical response across PBC stages, with stable fibrosis markers.

Seladelpar’s Impact on Pruritus in Primary Biliary Cholangitis, With Marlyn Mayo, MD

ByMarlyn Mayo, MD

October 30th 2025

Mayo explains findings from a pooled analysis of pruritus data from RESPONSE and ENHANCE highlighting seladelpar’s impact on itch in PBC.

Marlyn Mayo, MD: Improving Pruritus Management in PBC Care

ByAbigail Brooks, MA,Marlyn Mayo, MD

December 10th 2024

Mayo explains current shortcomings of pruritus care in PBC and what the additions of elafibranor, seladelpar, and other agents in development may offer.